UChicago Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics
Playback speed
10 seconds
Tumor Mutation Signatures (MSI/MMRd, HRD, POLE/POLD1, CDK12) in Cancer: What Is Their Correlation With Heritable Risk Factors & Targeted Therapy? Can They Help in Germline Cancer Workup?
17 views
February 15, 2021
Comments 0
Login to view comments.
Click here to Login
Videos